Dr. Mithu Maheswaranathan

Advertisement
Mithu Maheswaranathan, MDLupus | March 6, 2025
Dr. Mithu Maheswaranathan talks about the findings of a study which assessed obinutuzumab for patients with active lupus.
Mithu Maheswaranathan, MDRheumatology | January 2, 2025
Researchers sought to better address the gap in knowledge on acetaminophen safety in patients with osteoarthritis.
Mithu Maheswaranathan, MDLupus | November 11, 2024
Dr. Mithu Maheswaranathan discusses the link between vitamin D levels and pregnancy outcomes in women with lupus.
Mithu Maheswaranathan, MDRheumatology | October 4, 2024
A study sought to understand the use of herbal supplement treatment in adult patients with autoimmune skin diseases.
Mithu Maheswaranathan, MDPsoriatic Arthritis | August 1, 2024
The role of dietary and lifestyle interventions in the management of rheumatic disease is poorly understood.
Mithu Maheswaranathan, MDLupus | July 19, 2024
Dr. Mithu Maheswaranathan on a study that shows metformin is a promising complementary therapy for SLE.
Mithu Maheswaranathan, MDLupus | June 4, 2024
A study assessed glucocorticoid regimens on renal response, infections, and mortality in patients with lupus nephritis.
Mithu Maheswaranathan, MDRheumatology | April 29, 2024
There is increasing interest in the use of musculoskeletal ultrasound in pediatric rheumatology.
Mithu Maheswaranathan, MDRheumatology | April 12, 2024
A study analyzed the use of after-visit instructions at rheumatology clinics.
Mithu Maheswaranathan, MDOsteoarthritis | February 5, 2024
It is critical for physicians to be confident and comfortable in diagnosing and managing knee osteoarthritis.
Mithu Maheswaranathan, MDRheumatology | December 22, 2023
Mithu Maheswaranathan, MD, spoke about challenges, treatments, and trends in rheumatology, as well as upcoming advancements.
Mithu Maheswaranathan, MDRheumatology | December 6, 2023
A study aimed to create a benefit-versus-harm shared decision-making tool for hydroxychloroquine for patients with SLE.
Mithu Maheswaranathan, MDRheumatology | October 11, 2023
A study provided a unique characterization of a rare: large-vessel involvement from ANCA-associated vasculitis.
Mithu Maheswaranathan, MDRheumatoid Arthritis | October 11, 2023
A study sought to identify variables distinguishing inflammatory from noninflammatory arthritis in a large cohort.
Mithu Maheswaranathan, MDRheumatoid Arthritis | October 11, 2023
Ultra-low dose rituximab significantly reduced the rate of infections versus the standard low dosage in rheumatoid arthritis.
Mithu Maheswaranathan, MDRheumatology | October 11, 2023
Researchers examined changes in objective measures of cardiorespiratory function and patient-reported outcomes in lupus.
Mithu Maheswaranathan, MDRheumatology | October 11, 2023
A study sought to characterize racial differences in lupus clinical manifestations.
Mithu Maheswaranathan, MDRheumatology | October 11, 2023
VEXAS (vacuoles, E1-ubiquitin-activating enzyme, X-linked, autoinflammatory, somatic) syndrome is a newly discovered ...
Mithu Maheswaranathan, MDRheumatology | October 11, 2023
Two recent studies presented at the American College of Rheumatology (ACR) Convergence 2022 conference evaluated ANA ...
Mithu Maheswaranathan, MDCOVID-19 | October 11, 2023
It has been well demonstrated that patients with systemic autoimmune rheumatic diseases (SARDs) are at higher risk of ...
Advertisement